85 related articles for article (PubMed ID: 23694906)
1. Ligand selectivity of estrogen receptors by a molecular dynamics study.
Hu G; Wang J
Eur J Med Chem; 2014 Mar; 74():726-35. PubMed ID: 23694906
[TBL] [Abstract][Full Text] [Related]
2. Insights into ligand selectivity in estrogen receptor isoforms: molecular dynamics simulations and binding free energy calculations.
Zeng J; Li W; Zhao Y; Liu G; Tang Y; Jiang H
J Phys Chem B; 2008 Mar; 112(9):2719-26. PubMed ID: 18266357
[TBL] [Abstract][Full Text] [Related]
3. Computational insights into the mechanism of ligand unbinding and selectivity of estrogen receptors.
Shen J; Li W; Liu G; Tang Y; Jiang H
J Phys Chem B; 2009 Jul; 113(30):10436-44. PubMed ID: 19583238
[TBL] [Abstract][Full Text] [Related]
4. Prediction of estrogen receptor β ligands potency and selectivity by docking and MM-GBSA scoring methods using three different scaffolds.
Balaji B; Ramanathan M
J Enzyme Inhib Med Chem; 2012 Dec; 27(6):832-44. PubMed ID: 21999568
[TBL] [Abstract][Full Text] [Related]
5. Differential recognition of resveratrol isomers by the human estrogen receptor-alpha: molecular dynamics evidence for stereoselective ligand binding.
Abou-Zeid LA; El-Mowafy AM
Chirality; 2004 Mar; 16(3):190-5. PubMed ID: 14770416
[TBL] [Abstract][Full Text] [Related]
6. Molecular modeling and molecular dynamics simulation studies on the interactions of hydroxylated polychlorinated biphenyls with estrogen receptor-β.
Li X; Ye L; Wang X; Shi W; Qian X; Zhu Y; Yu H
Arch Environ Contam Toxicol; 2013 Oct; 65(3):357-67. PubMed ID: 23712771
[TBL] [Abstract][Full Text] [Related]
7. Use of binding energy in comparative molecular field analysis of isoform selective estrogen receptor ligands.
Wolohan P; Reichert DE
J Mol Graph Model; 2004 Sep; 23(1):23-38. PubMed ID: 15331051
[TBL] [Abstract][Full Text] [Related]
8. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.
van Lipzig MM; ter Laak AM; Jongejan A; Vermeulen NP; Wamelink M; Geerke D; Meerman JH
J Med Chem; 2004 Feb; 47(4):1018-30. PubMed ID: 14761204
[TBL] [Abstract][Full Text] [Related]
9. Computational Insights into Ligand Selectivity of Estrogen Receptors from Pharmacophore Modeling.
Fang J; Shen J; Cheng F; Xu Z; Liu G; Tang Y
Mol Inform; 2011 Jun; 30(6-7):539-49. PubMed ID: 27467155
[TBL] [Abstract][Full Text] [Related]
10. Conformational dynamics of the estrogen receptor alpha: molecular dynamics simulations of the influence of binding site structure on protein dynamics.
Celik L; Lund JD; Schiøtt B
Biochemistry; 2007 Feb; 46(7):1743-58. PubMed ID: 17249692
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for the β-adrenergic receptor subtype selectivity of the representative agonists and antagonists.
Roy KK; Saxena AK
J Chem Inf Model; 2011 Jun; 51(6):1405-22. PubMed ID: 21534556
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
[TBL] [Abstract][Full Text] [Related]
13. Interaction of tetrahydrocrysene ketone with estrogen receptors alpha and beta indicates conformational differences in the receptor subtypes.
Tyulmenkov VV; Klinge CM
Arch Biochem Biophys; 2000 Sep; 381(1):135-42. PubMed ID: 11019829
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of carborane-containing estrogen receptor-beta (ERβ)-selective ligands.
Ohta K; Ogawa T; Oda A; Kaise A; Endo Y
Bioorg Med Chem Lett; 2015 Oct; 25(19):4174-8. PubMed ID: 26298498
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes.
Meyers MJ; Sun J; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA
J Med Chem; 1999 Jul; 42(13):2456-68. PubMed ID: 10395487
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
[TBL] [Abstract][Full Text] [Related]
17. Structure-based design of estrogen receptor-beta selective ligands.
Manas ES; Unwalla RJ; Xu ZB; Malamas MS; Miller CP; Harris HA; Hsiao C; Akopian T; Hum WT; Malakian K; Wolfrom S; Bapat A; Bhat RA; Stahl ML; Somers WS; Alvarez JC
J Am Chem Soc; 2004 Nov; 126(46):15106-19. PubMed ID: 15548008
[TBL] [Abstract][Full Text] [Related]
18. Selectivity of neutral/weakly basic P1 group inhibitors of thrombin and trypsin by a molecular dynamics study.
Wu EL; Han K; Zhang JZ
Chemistry; 2008; 14(28):8704-14. PubMed ID: 18680136
[TBL] [Abstract][Full Text] [Related]
19. Simulation of the different biological activities of diethylstilbestrol (DES) on estrogen receptor alpha and estrogen-related receptor gamma.
Nam K; Marshall P; Wolf RM; Cornell W
Biopolymers; 2003 Jan; 68(1):130-8. PubMed ID: 12579585
[TBL] [Abstract][Full Text] [Related]
20. Molecular determinants of ER alpha and ER beta involved in selectivity of 16 alpha-iodo-7 beta estradiol.
Bhat RA; Stauffer B; Unwalla RJ; Xu Z; Harris HA; Komm BS
J Steroid Biochem Mol Biol; 2004 Jan; 88(1):17-26. PubMed ID: 15026080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
